Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of <i>Trypanosoma cruzi</i> Infection
Chagas cardiomyopathy is caused by <i>Trypanosoma cruzi</i> (<i>Tc</i>). We identified two candidate antigens (TcG2 and TcG4) that elicit antibodies and T cell responses in naturally infected diverse hosts. In this study, we cloned <i>TcG2</i> and <i>TcG4<...
Main Authors: | Nandadeva Lokugamage, Subhadip Choudhuri, Carolina Davies, Imran Hussain Chowdhury, Nisha Jain Garg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/1/96 |
Similar Items
-
The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice
by: Andréa P de Souza, et al.
Published: (2010-09-01) -
Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research
by: Concepción J. Puerta, et al.
Published: (2023-01-01) -
Immunopathology of cardiomyopathy in the experimental Chagas disease
by: Milena BP Soares, et al.
Published: (1999-09-01) -
Chagas Disease: Detection of <i>Trypanosoma cruzi</i> by a New, High-Specific Real Time PCR
by: Simone Kann, et al.
Published: (2020-05-01) -
Chagas disease reactivation in a heart transplant patient infected by domestic Trypanosoma cruzi discrete typing unit I (TcIDOM)
by: Jaime A. Costales, et al.
Published: (2015-08-01)